Peyronie's Disease Questionnaire (PDQ)

Evaluates symptoms & psychological effects in patients with PD who have had vaginal intercourse within the last 3 months

Audience: PRACTITIONER

Published by SMSNA

Revision 2 ยท Published March 20, 2026

Citation

This material was delivered to SMSNA under license from Keenova Therapeutics plc. No reproduction or dissemination of the material for commercial gain is permitted without the consent of Keenova Therapeutics plc, or one of its affiliates.

 

Hellstrom WJ, Feldman R, Rosen RC, Smith T, Kaufman G, Tursi J. Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire. J Urol. 2013 Aug;190(2):627-34. doi: 10.1016/j.juro.2013.01.090. Epub 2013 Jan 31. PMID: 23376705.

Summary

The PD Questionnaire (PDQ) is a self-administered and standardized questionnaire with 15-items created for the intralesional collagenase trials (IMPRESS I and II). It has proven to be highly responsive to symptom changes in men with PD, making it a valuable and effective tool for clinical practice and research. PDQ evaluates symptoms and psychological effects in patients with PD who have had vaginal intercourse within the last 3 months, considering the most recent sexual experience when completing the questionnaire.

 

Scoring

The results section includes a total PDQ score and scores for 3 domains (Psychological/Physical Symptoms, Penile Domain Score & Symptoms Bother Domain Score). Additionally, 2 unscored yes/no questions (Q12 & Q14) will trigger a result if answered "yes."

 

 

Considerations

This material was delivered to SMSNA under license from Keenova Therapeutics plc. No reproduction or dissemination of the material for commercial gain is permitted without the consent of Keenova Therapeutics plc, or one of its affiliates.

Instructions

Tags

Literature

Revisions

Current: Revision 2

About this evaluation